Related references
Note: Only part of the references are listed.Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database
Jean-Baptiste Bossard et al.
CLINICAL DRUG INVESTIGATION (2016)
Abuse Potential of Pregabalin
Ole Schjerning et al.
CNS DRUGS (2016)
A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database
Stefania Chiappini et al.
CNS DRUGS (2016)
Pregabalin concentrations in post-mortem blood-A two year study
Jane A. Eastwood et al.
FORENSIC SCIENCE INTERNATIONAL (2016)
Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database
K. Asomaning et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2016)
Use of Pregabalin - A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential
O. Schjerning et al.
PHARMACOPSYCHIATRY (2016)
Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history
Damien Driot et al.
THERAPIE (2016)
National Institutes of Health Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain
David B. Reuben et al.
ANNALS OF INTERNAL MEDICINE (2015)
Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis
B. M. Mishriky et al.
BRITISH JOURNAL OF ANAESTHESIA (2015)
Identification and Management of Alcohol Withdrawal Syndrome
Antonio Mirijello et al.
DRUGS (2015)
Time to Improvement of Pain and Sleep Quality in Clinical Trials of Pregabalin for the Treatment of Fibromyalgia
Lesley M. Arnold et al.
PAIN MEDICINE (2015)
Pregabalin Dependence: A Case Report
Athar Halaby et al.
CURRENT DRUG SAFETY (2015)
Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data
Jacob P. Prunuske et al.
BMC HEALTH SERVICES RESEARCH (2014)
Benzodiazepine dependence and its treatment with low dose flumazenil
Sean David Hood et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Factors associated with pregabalin dispensing at higher than the approved maximum dose
Robert Boden et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Pregabalin role in inhibition of morphine analgesic tolerance and physical dependency in rats
Parisa Hasanein et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Profiles of pregabalin and gabapentin abuse by postmortem toxicology
Margareeta Hakkinen et al.
FORENSIC SCIENCE INTERNATIONAL (2014)
Pregabalin serum levels in apprehended drivers
Pirkko Kriikku et al.
FORENSIC SCIENCE INTERNATIONAL (2014)
Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder
Siegfried Kasper et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
National Use of Prescription Medications for Insomnia: NHANES 1999-2010
Suzanne M. Bertisch et al.
SLEEP (2014)
Gabapentinoid Abuse in Order to Potentiate the Effect of Methadone: A Survey among Substance Misusers
Colin R. W. Baird et al.
EUROPEAN ADDICTION RESEARCH (2014)
Gabapentin Treatment for Alcohol Dependence A Randomized Clinical Trial
Barbara J. Mason et al.
JAMA INTERNAL MEDICINE (2014)
Pharmacotherapies for cannabis dependence
Kushani Marshall et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Alpha(2)-adrenergic agonists for the management of opioid withdrawal
Linda Gowing et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice
Auxiliadora Aracil-Fernandez et al.
ADDICTION BIOLOGY (2013)
Pregabalin abuse among opiate addicted patients
Martin Grosshans et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Pregabalin abuse and dependence in Germany: results from a database query
Maximilian Gahr et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Pregabalin abuse after past substance-seeking behavior
Georgios Papazisis et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Concerns About Pregabalin: Further Experience With Its Potential of Causing Addictive Behaviors
Maximilian Gahr et al.
JOURNAL OF ADDICTION MEDICINE (2013)
CANNABINOID AND OPIOID INTERACTIONS: IMPLICATIONS FOR OPIATE DEPENDENCE AND WITHDRAWAL
J. L. Scavone et al.
NEUROSCIENCE (2013)
National trends of psychotropic medication use among patients diagnosed with anxiety disorders: Results from Medical Expenditure Panel Survey 2004-2009
Chung-Hsuen Wu et al.
JOURNAL OF ANXIETY DISORDERS (2013)
Pregabalin for Alcohol Dependence: A Critical Review of the Literature
Riccardo Guglielmo et al.
ADVANCES IN THERAPY (2012)
Efficacy and Safety of Pregabalin in the Treatment of Alcohol Withdrawal Syndrome: A Randomized Placebo-Controlled Trial
Anna Foerg et al.
ALCOHOL AND ALCOHOLISM (2012)
Elucidating the Mechanism of Action of Pregabalin α2δ as a Therapeutic Target in Anxiety
Juan-Antonio Mico et al.
CNS DRUGS (2012)
Focal nonconvulsive seizures during detoxification for benzodiazepine abuse
Anna Albiero et al.
EPILEPSY & BEHAVIOR (2012)
Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice
J. Bobes et al.
EUROPEAN PSYCHIATRY (2012)
Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence
Panagiotis Oulis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Pregabalin in clinical psychiatry and addiction: pros and cons
Giovanni Martinotti
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Pregabalin Misuse-Related Issues; Intake of Large Dosages, Drug-Smoking Allegations, and Possible Association With Myositis Two Case Reports
Dario Carrus et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial
Sallie J. Hadley et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults
Barbara J. Mason et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Pregabalin for the Reduction of Opiate Withdrawal Symptoms
Nina Kaemmerer et al.
PSYCHIATRISCHE PRAXIS (2012)
Earlier discovery of pregabalin's dependence potential might have been possible
Ola Caster et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Pregabalin is a potent and selective ligand for α2δ-1 and α2δ-2 calcium channel subunits
Zheng Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Importance of Gabapentin Dose in Treatment of Opioid Withdrawal
Mehrdad Salehi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Pregabalin abuse: a case report / Pregabalin kötüye kullanımı: Bir olgu sunumu
Ilhan Yargic et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers
Aryeh I. Herman et al.
PSYCHOPHARMACOLOGY (2011)
Is There a Recreational Misuse Potential for Pregabalin? Analysis of Anecdotal Online Reports in Comparison with Related Gabapentin and Clonazepam Data
Fabrizio Schifano et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2011)
Effects of Pregabalin on Subjective Sleep Disturbance Symptoms during Withdrawal from Long-Term Benzodiazepine Use
Gabriel Rubio et al.
EUROPEAN ADDICTION RESEARCH (2011)
Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome
Laura Amato et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial
Giovanni Martinotti et al.
ADDICTION (2010)
Pregabalin Abuse, Dependence, and Withdrawal: A Case Report
Martin Grosshans et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Pregabalin in the Treatment of Alcohol and Benzodiazepines Dependence
Panagiotis Oulis et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system
Sofie Schwan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome
M. Di Nicola et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial
G. Martinotti et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
A Double-Blind Trial of Gabapentin Versus Lorazepam in the Treatment of Alcohol Withdrawal
Hugh Myrick et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
The Increased Trafficking of the Calcium Channel Subunit α2δ-1 to Presynaptic Terminals in Neuropathic Pain Is Inhibited by the α2δ Ligand Pregabalin
Claudia S. Bauer et al.
JOURNAL OF NEUROSCIENCE (2009)
Effect of add-on gabapentin on opioid withdrawal symptoms in opium-dependent patients
Gholam R. Kheirabadi et al.
ADDICTION (2008)
Efficacy and safety of pregabalin in alcohol dependence
Giovanni Martinotti et al.
ADVANCES IN THERAPY (2008)
Pregabalin overdose with benign outcome
Petros Nikolaos Karamanakos et al.
CLINICAL TOXICOLOGY (2008)
Clinical factors influencing the prescription of antidepressants and benzodiazepines: Results from the European study of the epidemiology of mental disorders (ESEMeD)
Koen Demyttenaere et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
The alcohol withdrawal syndrome
A. McKeon et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Differential modulation of K(+-)evoked H-3-neurotransmitter release from human neocortex by gabapentin and pregabalin
B. Brawek et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
An update on therapeutics for tobacco dependence
Tim Lancaster et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model
Yuichi Takeuchi et al.
NEUROPHARMACOLOGY (2007)
Challenges in the development of prescription opioid abuse-deterrent formulations
Nathaniel P. Katz et al.
CLINICAL JOURNAL OF PAIN (2007)
Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey
Caroline Victorri-Vigneau et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Pharmacology and mechanism of action of pregabalin:: The calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery
Charles P. Taylor et al.
EPILEPSY RESEARCH (2007)
Structural determinants for high-affinity zolpidem binding to GABA-A receptors
Feyza Sancar et al.
MOLECULAR PHARMACOLOGY (2007)
Effects of abstinence from tobacco: Valid symptoms and time course
John R. Hughes
NICOTINE & TOBACCO RESEARCH (2007)
Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin
Mark J. Field et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effectiveness and time to onset of pregabalin in patients with neuropathic pain
R. Freynhagen et al.
SCHMERZ (2006)
Pregabalin is effective against behavioral and electrographic seizures during alcohol withdrawal
Howard C. Becker et al.
ALCOHOL AND ALCOHOLISM (2006)
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
H Breivik et al.
EUROPEAN JOURNAL OF PAIN (2006)
The cannabis withdrawal syndrome
AJ Budney et al.
CURRENT OPINION IN PSYCHIATRY (2006)
The diagnosis and management of benzodiazepine dependence
H Ashton
CURRENT OPINION IN PSYCHIATRY (2005)
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone:: a review of case reports and epidemiological data
G Hajak et al.
ADDICTION (2003)
Management of drug and alcohol withdrawal
TR Kosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
K Fink et al.
NEUROPHARMACOLOGY (2002)